Etid klinik pou Atak kè nan Kansas
3 etid pou Atak kè ap chèche patisipan nan sit nan Kansas.
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Kansas Nephrology Physicians, PA, Wichita
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- University of Kansas Hospital, Kansas City
- Cotton O Neil Clinical Res Center, Topeka
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Hutchinson Clinic PA, Hutchinson
- University of Kansas Medical Center, Kansas City
- Midwest Heart and Vascular Specialists, Overland Park
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.